Master of Pharmacy (Pharmaceutics)

Size: px
Start display at page:

Download "Master of Pharmacy (Pharmaceutics)"

Transcription

1 Study & Evaluation Scheme of Master of Pharmacy (Pharmaceutics) [Applicable w.e.f. Academic Session till revised] TEERTHANKER MAHAVEER UNIVERSITY N.H.-24, Delhi Road, Moradabad, Uttar Pradesh Website: ( ) Page 1 of 16

2 TEERTHANKER MAHAVEER UNIVERSITY (Established under Govt. of U. P. Act No. 30, 2008) Delhi Road, Bagarpur, Moradabad (U.P) Study & Evaluation Scheme of MASTER OF PHARMACY SUMMARY Programme : M. Pharm. (Pharmaceutics) Duration : Two years full time Medium : English Minimum Required Attendance : 75 % Credit Maximum Credits Minimum credits required for degree : 95 : 90 Assessment Internal External Total : Internal Evaluation (Theory Papers) : Clas s Test I Clas s Test II Clas s Test III Continuou s Evaluatio n Semin ar Total Theory Practical Duration of Examination : External Internal External Internal 3 hrs. 1.5 hrs. 4 hrs. 4 hrs. To qualify the course a student is required to secure a minimum of 40% marks in aggregate in the end semester examination and teachers continuous evaluation (i.e. both internal and external). A candidate who secures less than 40% of marks in a course shall be deemed to have failed in that course. The student should have overall 50% marks in a semester to clear the semester. In case a student has more than 40% in each course but less than 50% overall in a semester he/she shall re-appear in one or two course(s) to improve the percentage. There will be three Class Tests in a semester and an average of the marks obtained in best two tests will be computed (cumulatively) for the final result. The class tests would comprise of five questions. Student shall have to answer three questions out of which one question will be compulsory. Each question would be of five marks. Question Paper Structure: 1. The question paper shall consist of eight questions. Out of which first question shall be of short answer type (not exceeding 50 words) and will be compulsory. Question No. 1 shall contain 8 parts representing all units of the syllabus and students shall have to answer any five (weightage 4 marks each). 2. Out of the remaining seven questions, a student shall be required to attempt any five questions. There will be minimum one and maximum two questions from each unit of the syllabus. The weightage of Question No. 2 to 8 shall be 10 marks each. ( ) Page 2 of 16

3 Study & Evaluation Scheme Programme: M. Pharm. Semester I Course Subject Periods Evaluation Scheme S.N. Code L T P C Internal External Total 1 MPA101 Modern Analytical Techniques MPU101 Pharmaceutical Biostatics and Computer Application 3 MPU102 Product Development MPA151 Modern Analytical Techniques (MAT) Lab 5 MPU152 Product Development Lab Total Semester II Course Subject Periods Credits Evaluation Scheme S.N. Code L T P Internal External Total 1 MPU201 Pharmaceutical Production Management 2 MPU202 Recent Advances in Drug Delivery System 3 MPU203 Bio-pharmaceutics & Pharmacokinetics 4 MPU251 Research Project Synopsis MPU252 Recent Advances in Drug Delivery System Lab 6 MPU253 Bio-pharmaceutics & Pharmacokinetics Lab Total Semester III Course Subject Periods Credits Evaluation Scheme S.N. Code L T P Internal External Total 1 MPU351 Research Project Phase -I Total Semester IV Course Subject Periods Credits Evaluation Scheme S.N. Code L T P Internal External Total 1 MPU451 Research Project Phase -II (Thesis compilation and Viva-Voce) Total Research Project shall be carried out in different stages. It will commence with submission and approval of synopsis in second semester. The experimental work shall be carried out in two phases i.e. in III & IV semesters. Note: L Lecture T- Tutorial P- Practical C- Credits 1L = 1Hr 1T= 1 Hr 1P=1 Hr 1C =1Hr of Theory paper = 2Hrs of Practical ( ) Page 3 of 16

4 M. Pharm. Semester I MODERN ANALYTICAL TECHNIQUE Course Code: MPA101 L-4, T-2, P-0, C-5 Objective: The basic objective of this course is to get familiar with Principle, theory & instrumentation of sophisticated pharmaceutical analysis instruments and the interpretation of their spectra. Unit - 1 Principle, theory & instrumentation of UV-Visible spectroscopy, it s utility in structural qualitative and quantitative analysis of drug molecules, Woodward Fischer rules and use of Shiff s reagents for elucidation of structure. Unit 2 Infrared spectroscopy, I.R radiation and its interaction with organic molecules, vibrational mode of bonds, instrumentation and application, effect of hydrogen bonding and conjugation on absorption bands, interpretation of IR Spectra, FTIR and ATR. Unit 3 Nuclear magnetic resonance spectroscopy: chemical shift concept, isotopic nuclei, reference standards and solvents. 1 H NMR spectra, coupling constants, interpretation of spectra, decouplingdouble resonance and shift reagent methods. Principles of FT-NMR with reference to 13 C NMR, free induction decay. Spin-spin and spin-lattice relaxation phenomenon. Nuclear overhauser enhanced 13 C NMR spectra, their interpretation and application. Unit 4 Mass spectrometry: Basic principles and brief outline of instrumentation. Ion formation, molecular ion, metastable ion, fragmentation process in relation to molecular structure and functional groups. Relative abundance of isotopes, chemical ionization, GC-MS and LC/MS. Interpretation of spectra of simple molecules. Unit 5 Chromatographic techniques: Principles of separation and application of Column, Paper, Thin layer and Gas chromatography, HPLC, HPTLC, Electrophoresis. Instrumentation of HPLC, Reverse phase columns. Pharmaceutical evaluation of drug in biological fluids- bioassays. Radioimmunoassay. Recommended Books 1. Willard, H.H., Merrit, L.L., Dean, J.A., Settle, P.A., Instrumental Methods of Analysis, Van Nostrand. 2. Skoog, D.A., Heller, F.J., Nieman, T.A., Principles of Instrumental Analysis, WB Saunders. 3. Haswell, S.J., ed. Atomic Absorption Spectroscopy, Elsevier. 4. Ardrey, R.E., Pharmaceutical Mass Spectra, Pharmaceutical Press, London. 5. Sethi, P.D., Quantitative Analysis of Pharmaceutical Formulations, CBS Publishers, New Delhi. 6. Kalsi, P.S., Spectroscopy of Organic Compounds, New Age Publishers, New Delhi. 7. Gross J.H., Mass Spectrometry, Springer Berlin, Heidelberg. 8. Haffmann D. H., Advances in Chromatography, Marcel Dekker. 9. Robert D. Braun, Introduction to Instrumental Analysis, McGraw-Hill. 10. Wilfried, M.A. Niessen- Liquid Chromatography-Mass Spectrometry, Marcel Dekker. *Latest editions of all the suggested books are recommended. ( ) Page 4 of 16

5 Semester I PHARMACEUTICAL BIOSTATICS AND COMPUTER APPLICATIONS Course Code: MPU101 L-4, T-2, P-0, C-5 Objective: The basic objective of this course is to get familiar with pharmaceutical biostatics and computer applications. Unit - 1 Methods of collection of data, classifications and graphical representation of data. Binomial and normal probability distribution. Polygon, histogram, measure of central tendency. Significance of statistical methods, probability, degree of freedom, measures of variation - Standard deviation, Standard error. Unit - 2 Sampling, sample size and power. Statistical inference and hypothesis. Tests for statistical significance: student t-test, Chi-square test, confidence level, Null hypothesis. Unit - 3 Linear regression and correlation. Analysis of Variance (one way and two way). Factorial designs (including fraction factorial design). Theory of probability, Permutation and Combination, Ratios, Percentage and Proportion. Two way ANOVA and Multiple comparison procedures. Unit - 4 Non-parametric tests, Experimental design in clinical trials, Statistical quality control, Validation, Optimization techniques and Screening design. Correlation and regression, least square method, significance of coefficient of correlation, nonlinear regression. Unit - 5 Bioassays-calculations of doses response relationships, LD 50, ED 50. Applications of software for statistical calculation viz. SPSS, foxtron. Recommended Books 1. Bolton, Pharmaceuticals Statistics- Practical & Clinical Applications, Marcel & Dekker, New York. 2. Fisher, R.A., Statistical Methods for Research Works, Oliver & Boyd, Edinburgh. 3. Chow, Statistical Design and Analysis of Stability Studies, Marcel Dekker, New York. 4. Buncher, Statistics in the Pharmaceutical Industry, Marcel Dekker, New York. 5. Finney, D.J., Statistical Methods in Biological Assays, Hafner, New York. 6. Montgomery, D.C., Introduction to Statistical Quality Control, Willy. 7. Lipschutz, Introduction to Probability and Statistics, McGraw-Hill. 8. Li wan Po, Statistics for Pharmacist, Wiley-Blackwell. * Latest editions of all the suggested books are recommended. ( ) Page 5 of 16

6 Semester I PRODUCT DEVELOPMENT Course Code: MPU102 L-4, T-2, P-0, C-5 Objective: The basic objective of this course is to get familiar with product development. Unit-1 PREFORMULATION STUDIES Timings and goals of Preformulation. pre-formulation methodology, solid stat properties, partition coefficient, solubility, dissolution, crystal from the stability, compatibility tests, dissolution of drug substances and dosage forms, Pediatric & geriatric aspects of formulation. Unit -2 PHARMACEUTICAL PROCESS VALIDATION Regulatory basis, validation of sterile products, solid dosage forms, process. Drug additive interaction. Unit-3 STABILITY Theoretical considerations, Degradative pathways, Stability indicating assays, Influence of packaging components on dosage form stability, Stabilization of Pharmaceutical formulations (solid, liquid and semi solid formulations). Unit-4 Evaluation of Pharmaceutical formulations in vitro and in vivo studies and their correlation. Levels and types of IV-IVC. Unit -5 POLYMERS Types, Pharmaceutical Application, Molecular Weight Determination, Conformation of dissolved linear macromolecules, Polymer solutions, Polymer in solid state, Fabrication. PACKAGING DEVELOPMENT- Packaging materials, Types, Labeling, Preformulation screening of packaging components. Recommended Books 1. Bannker G.S., & Rhodes C.T., Modern Pharmaceutics, Marcel Dekker, New York. 2. Liberman H.A. et al, Pharmaceutical Dosage Forms-Tablets, Marcel Dekker, New York. 3. Lachman L, Lieberman H.A. & Kanig J.L. The Theory & Practice of Industrial Pharmacy. Varghese Publishing Home. 4. Aulton M.E., Pharmaceutics-The Science of Dosage form Design, Churchill Livingstone. 5. Liberman H.A. et al, Pharmaceutical Dosage Forms-Parenterals, Marcel Dekker, New York. 6. Carstensen J.T., Drug Stability-Principles & Practice, Marcel Dekker, New York. 7. Malmsten M., Surfactants and Polymers in Drug Delivery, Marcel Dekker, New York. 8. Ansel H.A. - Pharmaceutical Dosage Forms, Lippincott Williams & Wilkins. 9. Sarfaraz K. Niazi, Handbook of Preformulations: Chemical, Biological and Botanical Drugs, CRC Press. *Latest editions of all the suggested books are recommended ( ) Page 6 of 16

7 Semester I MODERN ANALYTICAL TECHNIQUE (MAT) LAB Course Code: MPA151 L-0, T-0, P-8, C-4 Objective: The basic objective of this course is to get familiar with different analytical instruments. Based on the Course Code: MPA101 ( ) Page 7 of 16

8 Semester I PRODUCT DEVELOPMENT LAB Course Code: MPU152 L-0, T-0, P-8, C-4 Objective: The basic objective of this course is to get familiar with product development practicals. Based on Course Code MPU103 ( ) Page 8 of 16

9 Semester II PHARMACEUTICAL PRODUCTION MANAGEMENT Course Code: MPU201 L-4, T-2, P-0, C-5 Objective: The basic objective of this course is to get familiar with pharmaceutical production management. Unit-1 Status of Pharmaceutical industry with special reference to post GATT scenario. Project planning and implementation. Transfer of Technology. Unit-2 Master formula generation and SOP. Pilot plant scale up techniques. Unit-3 Factory layout, Material Management: Unit-4 Process optimization and automation in pharmaceutical manufacturing. Unit-5 Inventory control. Different Systems of inventory control. Import and Export regulations laws and methods to obtain I & E licenses, I and E regulations USA, EU and Japanese perspectives. Recommended Books 1. Banker G.S., & Rhodes C.T., Modern Pharmaceutics, Marcel Dekker, New York. 2. Remington, The Science & Practice of Pharmacy, Lippincott. William & Wilkins. 3. Lachman L, Lieberman H.A. & Kanig J.L., The Theory & Practice of Industrial Pharmacy, Varghese Publishing Home. 4. Aulton M.E., Pharmaceutics The Science of Dosage form Design, Churcill Livingstone. 5. Levin M.A., Pharmaceutical Process Scale up, Marcel Dekker, New York. 6. Dutta A.K., Material Management, Prentice Hall India. 7. Chary S.N., Production and Operative Management, Tata-Mcgraw Hill, India. 8. Kennedy T., Pharmaceutical Project Management, Marcel Dekker, New York. * Latest editions of all the suggested books are recommended ( ) Page 9 of 16

10 Semester II RECENT ADVANCES IN DRUG DELIVERY SYSTEM Course Code: MPU202 L-4, T-2, P-0, C-5 Objective: The basic objective of this course is to get familiar with novel techniques and advances in drug delivery system. Unit-1 Formulation considerations with special emphasis on release patterns. Sustained and Controlled release- oral, dental, nasal, ocular & parenteral systems. Unit-2 Fast Release- Introduction, formulation & evaluation. Unit-3 Transdermal Drugs Delivery System- Factors influencing transdermal delivery, formulation & evaluation including Iontophoresis and Ionophoresis. Unit-4 Target Oriented Drug Delivery Systems- prodrugs, Liposome, Niosome, nanoparticles Microspheres and microparticles. Lipoproteins Activated Carbons, Cellular Carriers, Antibodies, DNA, And Low Molecular Weight Proteins. Hormones, Dextran & Polysaccharides, Synthetic Polymers, Nanoparticles, Microparticles fabrication techniques (Latest Advances). Unit-5 Nutraceuticals- introduction & scope. Recommended Books 1. Chien Y.W., Novel Drug Delivery Systems-Fundamentals, Developmental Concepts. Biomedical Assessment, Marcel Dekker, New York. 2. Chien Y.W., ed., Transdermal Controlled Systemic Medications, Marcel Dekker, New York. 3. Schreyer, H., Drug Targeting Technology Physical, Chemical & Biological Methods, Marcel Dekker, New York. 4. Banker G.S. & Rhodes C.T., Modern Pharmaceutics, Marcel Dekker, New York. 5. Gennaro A.R., Remington, The Science & Practice of Pharmacy, Lippincott. Williams & Wilkins. 6. Lachman L., Lieberman B.A & Kanig I.L., The Theory & Practice of Industrial Pharmacy, Varghese Publishing Home. 7. Aulton M.E., Pharmaceutics-The Science of Dosage form Design, Churchill Livingstone. 8. Potts R.O. & Guy R.H., Mechanism of Trans dermal Drug Delivery, Marcel Dekker, New York. * Latest editions of all the suggested books are recommended. ( ) Page 10 of 16

11 Semester II BIO-PHARMACEUTICS & PHARMACOKINETICS Course Code: MPU203 L- 4, T-2, P-0, C-5 Objective: The basic objective of this course is to get familiar with bio-pharmaceutics & pharmacokinetics. Unit-1 Drug Absorption Distribution & Disposition. Unit-2 Pharmacokinetics. Open one compartment, two compartment & three compartment models & their limitations. Non-compartmental pharmacokinetics. Graphical methods of calculating pharmacokinetic parameters. Unit-3 Factors influencing bio-availability, evaluation of bioavailability, bio-equivalence with reference to BCS. Unit-4 Dosage Regimens, Repetitive dosing and dose adjustments in renal and hepatic failure, individualization of dosage regimen. Unit-5 Pharmacokinetic applications in Clinical practice. Principles of clinical trial. Recommended Books 1. Notari, R.E., Biopharmaceutics and Pharmacokinetics An introduction, Marcel Dekker Inc. N.Y. 2. Rowland M., and Tozer T.N., Clinical Pharmacokinetics, Lea and Febriger, N.Y. 3. Wagner J.G., Fundamentals of Clinical Pharmacokinetics, Drugs Intelligence Publishers, Hamilton. 4. Wagner J.G., Pharmacokinetics for the Pharmaceutical Scientist, Technomic Publishing A.G. Basel, Switzerland. ( ) Page 11 of 16

12 Semester II RESEARCH PROJECT SYNOPSIS Course Code: MPU251 L-0, T-2, P-0, C-1 Objective: The basic objective of this course is to get familiar with the method, instrumentation and the technology of the topic that is selected for the dissertation. Guidelines: 1. The course will comprise of preparation of synopsis for the proposed research work to be done during third and fourth semester courses. 2. The allotted supervisor will provide guidelines and determine the topic of the research work based on thorough literature reviews. 3. The final presentation will be evaluated by the supervisor(s) concerned for 25 marks. 4. A committee of senior faculty of the institute including supervisor(s), will finally evaluates the quality of the proposed work and its relevance in the pharmaceutical field (out of 75 marks). ( ) Page 12 of 16

13 Semester II RECENT ADVANCES IN DRUG DELIVERY SYSTEM LAB Course Code MPU252 L-0, T-0, P-8, C-4 Objective: The basic objective of this course is to get familiar with practicals related novel techniques and advances in drug delivery system. Based on the Course Code: MPU202 ( ) Page 13 of 16

14 Semester II BIO-PHARMACEUTICS & PHARMACOKINETICS LAB Course Code: MPU253 L- 0, T-0, P-8, C-4 Objective: The basic objective of this course is to get familiar with pharmacokinetic practicals. Based on the Course Code: MPU203 ( ) Page 14 of 16

15 Semester III RESEARCH PROJECT (PHASE-I) (TO BE CONTINUED IN SEMESTER-IV) Course Code: MPU351 L- 0, T-0, P-48, C-24 Objective: The basic objective of this course is to represent the findings of the project that has been done in the dissertation. Guidelines: 1. The course will comprise of the confirmation of the proposed research work based on the initial experimentation to confirm the feasibility of the work. 2. The allotted supervisor(s) will provide guidelines with exploration of the line of action with recent trends of research in the related field and confirm global acceptability with regards to industry and academic problems. 3. The continuous literature survey and modification of experimental pathway will be taken in to practice with regular monitoring. 4. The candidate s performance will be evaluated by the supervisor(s) and the internal committee of at least three senior faculties in addition to the allotted supervisor(s). There will be atleast two seminars to be presented before the committee in this semester consisting of the progress of the research work. 5. Each seminar will be of 50 marks. ( ) Page 15 of 16

16 Semester IV RESEARCH PROJECT (PHASE II) (THESIS COMPILATION & VIVA-VOCE) Course Code: MPU451 L-0, T-0, P-48, C-24 Objective: The basic objective of this course is to present the findings of the project that has been carried out in different phases. Guidelines: 1. The progress of research work will be continuously evaluated by the supervisor(s) concerned. 2. There will be at least two presentations in this semester and each will be evaluated out of 25 marks by the internal committee of at least three senior faculties beside the allotted supervisor(s). 3. The external examiner appointed by the university will finally evaluate the thesis by way of viva- voce and presentation by the candidate out of the remaining 50 marks. ( ) Page 16 of 16

Master of Pharmacy (Pharmacology) [Applicable w.e.f. Academic Session till revised]

Master of Pharmacy (Pharmacology) [Applicable w.e.f. Academic Session till revised] Study & Evaluation Scheme of Master of Pharmacy (Pharmacology) [Applicable w.e.f. Academic Session 2011-12 till revised] TEERTHANKER MAHAVEER UNIVERSITY N.H.-24, Delhi Road, Moradabad, Uttar Pradesh-244001

More information

International Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW

International Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW International Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW SUKHDEV SINGH *1 AND JASBIR SINGH 2 1 Rayat Institute

More information

PHARMACEUTICAL VALIDATION AND QUALITY MANAGEMENT SYSTEM

PHARMACEUTICAL VALIDATION AND QUALITY MANAGEMENT SYSTEM Course Title Course Code PHARMACEUTICAL VALIDATION AND QUALITY MANAGEMENT SYSTEM QA204 Lecture : 04 Course Credit Practical : 04 Tutorial : 00 Total : 08 Course Objective To explain the students about

More information

WHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability

WHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability 2017 WHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability Eric C Buxton Clinical Associate Professor University of Wisconsin Madison School of Pharmacy, Division of Pharmacy

More information

Graduate Courses: Advanced Pharmaceutics Prerequisites: Course No: Instructor: Credits: Description:

Graduate Courses: Advanced Pharmaceutics Prerequisites: Course No: Instructor: Credits: Description: The following is a listing of courses offered by the Graduate Program in Pharmaceutical Science. Prerequisites and brief descriptions are included for each course. For more information on a particular

More information

BIOPHARMACEUTICS AND PHARMACOKINETICS

BIOPHARMACEUTICS AND PHARMACOKINETICS BIOPHARMACEUTICS AND PHARMACOKINETICS (JULIO 2015) Degree in PHARMACY University of Alcalá Academic year 2015/16 3 rd Year 1 st Season COURSE DESCRIPTION Title: Biopharmaceutics and Pharmacokinetics Code:

More information

BIOPHARMACEUTICS AND PHARMACOKINETICS. University of Alcalá. Academic year 2016/17 3 rd Year 1 st Season

BIOPHARMACEUTICS AND PHARMACOKINETICS. University of Alcalá. Academic year 2016/17 3 rd Year 1 st Season BIOPHARMACEUTICS AND PHARMACOKINETICS Degree in PHARMACY University of Alcalá Academic year 2016/17 3 rd Year 1 st Season COURSE DESCRIPTION Title: Biopharmaceutics and Pharmacokinetics Code: 570014 Degree:

More information

Analytical Methods Development and Validation

Analytical Methods Development and Validation Understanding and Implementing Efficient Analytical Methods Development and Validation Jay Breaux, Kevin Jones, and Pierre Boulas Analytical methods development and validation play important roles in the

More information

Design and Dosage Form. Dr. Deny Susanti

Design and Dosage Form. Dr. Deny Susanti Design and Dosage Form Dr. Deny Susanti Example 1 Aspirin tablet is stable but not as a liquid dosage form How to design liquid form? Soluble or dispersible aspirin tablets-to be dissolved in water Note:

More information

The course is taught by a team of UNC faculty and industry scientists. The course has been designed to provide the students an understanding of

The course is taught by a team of UNC faculty and industry scientists. The course has been designed to provide the students an understanding of Drug Metabolism MOPH 810 Fall 2009 Classes: 80 minute class twice a week Course Director: Dhiren R. Thakker Eshelman School of Pharmacy, UNC-Chapel Hill The course is taught by a team of UNC faculty and

More information

Since 1996, UAP is the pioneer in launching four years Bachelor of Pharmacy (B. Pharm

Since 1996, UAP is the pioneer in launching four years Bachelor of Pharmacy (B. Pharm Since 1996, UAP is the pioneer in launching four years Bachelor of Pharmacy (B. Pharm Hons.) program and one year Master of Science in Pharmaceutical Technology (MS. Pharm Tech) program. The Pharmacy department

More information

Guide. recombinant DNA proteins. for the elaboration of monographs on synthetic peptides and. European Pharmacopoeia

Guide. recombinant DNA proteins. for the elaboration of monographs on synthetic peptides and. European Pharmacopoeia Guide for the elaboration of monographs on synthetic peptides and recombinant DNA proteins European Pharmacopoeia European Directorate for the Quality of Medicines & HealthCare Edition Council of Europe,

More information

GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs)

GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs) GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs) DRAFT GUIDANCE This guidance document is for feedback purposes only Comments and suggestions regarding this draft document should be submitted within

More information

Setting Specifications

Setting Specifications 536 LCGC NORTH AMERICA VOLUME 22 NUMBER 6 JUNE 2004 www.chromatographyonline.com Setting Specifications Validation Viewpoint Specifications establish the criteria to which a drug substance or product should

More information

Master List of Professional Electives Course Title Description Credit Hours. Note: This class only meets for the last 7 class periods of the semester.

Master List of Professional Electives Course Title Description Credit Hours. Note: This class only meets for the last 7 class periods of the semester. Course Number PHTH7044 PHRX7064 PHRX704C PHRX706 PHTH8048 PHRX 904 PHRX 904 Master List of Professional Electives Course Title Description Credit Hours Advanced Cardiac Life Support Emphasis (P only) Advanced

More information

Abstract. Technical Aspects. Applying GastroPlus for Extensions of Biowaivers for BCS Class II Compounds 2

Abstract. Technical Aspects. Applying GastroPlus for Extensions of Biowaivers for BCS Class II Compounds 2 Abstract GastroPlus is a mechanistically based simulation software package that predicts absorption, pharmacokinetics, and pharmacodynamics in humans and animals. GastroPlus modeling and simulation has

More information

Application of Quality by Design (QbD) in product development. James E. Polli September 16, 2015

Application of Quality by Design (QbD) in product development. James E. Polli September 16, 2015 Application of Quality by Design (QbD) in product development James E. Polli jpolli@rx.umaryland.edu September 16, 2015 Pharmaceutical Equivalence Same active ingredient(s) Same dosage form Same route

More information

Pharmaceutical Sciences

Pharmaceutical Sciences SRI International Biosciences From Idea to IND Research on Disease Mechanisms Drug Discovery Drug Metabolism, Pharmacokinetics, & Toxicology Services Pharmaceutical Sciences Preclinical Development Planning

More information

Official Letter from the DOH

Official Letter from the DOH Issued Date 2009/04/02 Issued by DOH Ref. No 0980316268 RE The DOH issued an official letter to announce the implementation of the Guideline for BA/BE Studies on April 2, 2009 (Ref. No. 0980316265). Please

More information

Pharmaceutical Sciences/Medicinal Chemistry, M.S.

Pharmaceutical Sciences/Medicinal Chemistry, M.S. Pharmaceutical Sciences/Medicinal Chemistry, M.S. 1 Pharmaceutical Sciences/Medicinal Chemistry, M.S. SCHOOL OF PHARMACY (http://www.temple.edu/pharmacy) About the Program The School of Pharmacy offers

More information

A.N.U. M.PHARMACY SYLLABUS (WITH EFFECT FROM ACADEMIC YEAR) ACHARYA NAGARJUNA UNIVERSITY MASTER OF PHARMACY

A.N.U. M.PHARMACY SYLLABUS (WITH EFFECT FROM ACADEMIC YEAR) ACHARYA NAGARJUNA UNIVERSITY MASTER OF PHARMACY ACHARYA NAGARJUNA UNIVERSITY MASTER OF PHARMACY REGULATIONS AND SYLLABUS Four Semester Pattern (with effect from 2007-2008) 1.1 The Degree of Master of Pharmacy of the Nagarjuna University will be conferred

More information

Overview Stability testing is an essential part of drug development which ensures the quality, safety and efficacy of the drug for the lifetime of the drug product. Appropriate storage conditions can only

More information

PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL INDUSTRY

PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL INDUSTRY WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Vijayasree et al. SJIF Impact Factor 6.647 Volume 6, Issue 3, 367-874 Review Article ISSN 2278 4357 PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL

More information

SRI SATYA SAI UNIVERSITY OF TECHNOLOGY & MEDICAL SCIENCES

SRI SATYA SAI UNIVERSITY OF TECHNOLOGY & MEDICAL SCIENCES MPCS-101 MODERN ANALYTICAL TECHNIQUES (THEORY) 1. Spectroscopy: a. UV-Visible spectroscopy: Introduction, Theory, Laws, Instrumentation associated with UV-Visible spectroscopy, Choice of solvents and solvent

More information

Conjugated protein biotherapeutics

Conjugated protein biotherapeutics B i o P r o c e s s TECHNICAL Mass Spectrometric Conjugate Characterization Process Qualification of Recombinant Protein Hapten Conjugation Miao-Fang Lin, Margo Wilson, Michael V. Murray, and Greg W. Adams

More information

NOVEL DRUG DELIVERY SYSTEMS II

NOVEL DRUG DELIVERY SYSTEMS II NOVEL DRUG DELIVERY SYSTEMS II Polymer Science 1. Define Polymer. Describe its properties. 2. Classify polymers based on various criteria. 3. What are the ideal characteristics of biodegradable polymers?

More information

Name of Chapter & Details. Section-I

Name of Chapter & Details. Section-I Course Title Course Code APPLIED PHARMACEUTICAL ANALYSIS QA202 Lecture : 04 Course Credit Practical : 04 Tutorial : 00 Total : 08 Course Objectives To explain the students about application of various

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Review Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTRODUCTION AND GENERAL OVERVIEW OF PHARMACEUTICAL PROCESS VALIDATION: A REVIEW Pandita Rachna* 1, Rana A C

More information

STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS

STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS

More information

Model-based Technology Selection for Bioavailability Enhancement CPHI DAVID K. LYON, PH.D. OCTOBER 25, 2017

Model-based Technology Selection for Bioavailability Enhancement CPHI DAVID K. LYON, PH.D. OCTOBER 25, 2017 Model-based Technology Selection for Bioavailability Enhancement CPHI DAVID K. LYON, PH.D. OCTOBER 25, 2017 Biopharmaceutical Classification System Approximately 80% of drugs in the pharmaceutical compounds

More information

Evaluating single-use systems

Evaluating single-use systems B i o p r o c e s s Validation Extractables and Leachables from Single-Use Disposables Denise Bestwick and Raymond Colton Evaluating single-use systems for extractables and leachables is new territory

More information

The Five Key Elements of a Successful Metabolomics Study

The Five Key Elements of a Successful Metabolomics Study The Five Key Elements of a Successful Metabolomics Study Metabolomics: Completing the Biological Picture Metabolomics is offering new insights into systems biology, empowering biomarker discovery, and

More information

Regulatory Assessment

Regulatory Assessment Implementation of ICH Q8, Q9, Q10 Regulatory Assessment International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Presentation Overview Goal

More information

Guidance for Industry

Guidance for Industry Guidance for Industry ANDAs: Impurities in Drug Products DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should

More information

Drug Development and Incrementally Modified Drugs : Regulatory Perspective. American Association of Pharmaceutical Scientists October 27, 2015

Drug Development and Incrementally Modified Drugs : Regulatory Perspective. American Association of Pharmaceutical Scientists October 27, 2015 Drug Development and Incrementally Modified Drugs : Regulatory Perspective American Association of Pharmaceutical Scientists October 27, 2015 Larissa Lapteva, M.D., M.H.S., Division of Therapeutic Performance

More information

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE FORMULATION AND EVALUATION OF FUDOSTEINE FILM COATED IMMEDIATE RELEASE TABLETS M. CHANDRAKANTH, P. PREM KUMAR, MANOHAR BABU S Department

More information

Ensuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education

Ensuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education Ensuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education Loyd V. Allen, Jr., Ph.D. Professor & Chair Emeritus University of Oklahoma HSC College of Pharmacy Editor-in in-chief International

More information

Stability of Biological Products

Stability of Biological Products Stability of Biological Products Dr Jurgen Lindner Principal, BioPharma Consulting & Executive Secretary, APIMAA Biological Products Functional Proteins or Polypeptides (mab s, enzymes & inhibitors, growth

More information

Formulation and Evaluation of Gastro retentive Bilayer Tablets- Glimepiride as Sustained Release and Lisinopril as Immediate Release

Formulation and Evaluation of Gastro retentive Bilayer Tablets- Glimepiride as Sustained Release and Lisinopril as Immediate Release Farhat A et al / Int. J. of Pharmacy and Analytical Research Vol-5(4) 216 [658-669] IJPAR Vol.5 Issue 4 Oct - Dec -216 Journal Home page: ISSN:232-2831 Research article Open Access Formulation and Evaluation

More information

INDUSTRIAL TECHNOLOGY AND PACKAGING (ITP)

INDUSTRIAL TECHNOLOGY AND PACKAGING (ITP) Industrial Technology and Packaging (ITP) 1 INDUSTRIAL TECHNOLOGY AND PACKAGING (ITP) ITP Courses ITP 137. Electrical/Electronic Systems. 4 units Electrical and electronic circuit fundamentals. Essential

More information

Biopharmaceutics Applications in Drug Development

Biopharmaceutics Applications in Drug Development Biopharmaceutics Applications in Drug Development Edited by Rajesh Krishna Merck & Co., Inc. Rahwav, NJ. USA and Lawrence Yu Center for Drug Evaluation & Research Rockville, MD, USA 4y Springer Contents

More information

Introduction to CMC Regulatory Affairs

Introduction to CMC Regulatory Affairs Introduction to CMC Regulatory Affairs Bharathi Mamidipudi Regulatory Affairs Consultant II Syner-G Pharma Consulting, LLC Northeastern University, Boston November 10, 2016 My Background Experience ~4

More information

Rapid Extraction of Therapeutic Oligonucleotides from Primary Tissues for LC/ MS Analysis Using Clarity OTX, an Oligonucleotide Extraction Cartridge

Rapid Extraction of Therapeutic Oligonucleotides from Primary Tissues for LC/ MS Analysis Using Clarity OTX, an Oligonucleotide Extraction Cartridge Rapid Extraction of Therapeutic Oligonucleotides from Primary Tissues for LC/ MS Analysis Using Clarity OTX, an Oligonucleotide Extraction Cartridge G. Scott*, H. Gaus #, B. Rivera*, and M. McGinley* *Phenomenex,

More information

MASTER FILE PROCEDURES

MASTER FILE PROCEDURES MASTER FILE PROCEDURES Natural Health Products Directorate August 2006 Version 1.0 Our mission is to help the people of Canada maintain and improve their health, while respecting individual choices and

More information

KEYWORDS: Pharmaceutical Engineering, Chemical Engineering, Pharmaceutical Industry, Master Degree, Graduate Studies.

KEYWORDS: Pharmaceutical Engineering, Chemical Engineering, Pharmaceutical Industry, Master Degree, Graduate Studies. International Conference on Engineering Education and Research Progress Through Partnership 2004 VŠB-TUO, Ostrava, ISSN 1562-3580 Core Courses and Core Activities in the Pharmaceutical Engineering Program

More information

1. Checklist for Grant of permission to manufacture/import of Bulk Drug already approved in the country

1. Checklist for Grant of permission to manufacture/import of Bulk Drug already approved in the country 1. Checklist for Grant of permission to manufacture/import of Bulk Drug already approved in the country S no 1. Name of Applicant with address 2. Name of Drug 3. Therapeutic Class 4. Date of Approval Documents

More information

M. Pharm. (Pharmaceutical Management and Administration)

M. Pharm. (Pharmaceutical Management and Administration) M. Pharm. (Pharmaceutical Management and Administration) Second Semester Note: Each question Paper will contain seven questions and the candidates are required to attempt any Paper (MPH 201): Management

More information

Conventional versus Physiologically-Based (PB)-IVIVC: Revisiting Some Successful and Failed Conventional IVIVC Cases with PB-IVIVC

Conventional versus Physiologically-Based (PB)-IVIVC: Revisiting Some Successful and Failed Conventional IVIVC Cases with PB-IVIVC Conventional versus Physiologically-Based (PB)-IVIVC: Revisiting Some Successful and Failed Conventional IVIVC Cases with PB-IVIVC Nikunj Patel, Senior Research Scientist Simcyp (a Certara Company) AAPS

More information

PHARMACEUTICAL TESTING

PHARMACEUTICAL TESTING WHITEHOUSE, NJ PHARMACEUTICAL TESTING Pharmaceutical Expertise for GMP & CMC Testing Our Pharmaceutical Expertise With more than 20 years of experience in a variety of industries, our Whitehouse, New Jersey

More information

INTEGRATED STUDIES, SCIENCE AND BUSINESS VALLEY SANTAKA CENTRE FOR THE ADVANCED PHARMACEUTICAL AND HEALTH TECHNOLOGIES.

INTEGRATED STUDIES, SCIENCE AND BUSINESS VALLEY SANTAKA CENTRE FOR THE ADVANCED PHARMACEUTICAL AND HEALTH TECHNOLOGIES. 1 INTEGRATED STUDIES, SCIENCE AND BUSINESS VALLEY SANTAKA CENTRE FOR THE ADVANCED PHARMACEUTICAL AND HEALTH TECHNOLOGIES www.lsmuni.lt 2 3 About Lithuanian University of Health Sciences Lithuanian University

More information

Formulation Development of New Chemical Entities (NCEs) Dr. Mariella Artusi Pharmaceutical Development Dept. Monza

Formulation Development of New Chemical Entities (NCEs) Dr. Mariella Artusi Pharmaceutical Development Dept. Monza Formulation Development of New Chemical Entities (NCEs) Dr. Mariella Artusi Pharmaceutical Development Dept. Monza HorizonChem 2018, March, 6th 2018 1 Content Rottapharm Biotech : Company Overview Formulation

More information

PHARMACOLOGY. Dr Paul Spiers, Dept of Pharmacology & Therapeutics Tel ,

PHARMACOLOGY. Dr Paul Spiers, Dept of Pharmacology & Therapeutics Tel , PHARMACOLOGY COURSE COORDINATOR: Dr Paul Spiers, Dept of Pharmacology & Therapeutics Tel 896 2146, spiersj@tcd.ie ECTS Value 10 Credits Contact Hours 46 hrs lectures 2 tutorials 3 hr 2 computer sessions

More information

Post-Baccalaureate Program in Pharmaceutical Science. Accelerate your career

Post-Baccalaureate Program in Pharmaceutical Science. Accelerate your career Post-Baccalaureate Program in Pharmaceutical Science Accelerate your career pharmsci.uci.edu pharmsci-grad@uci.edu 949.824.1991 Improve your career options The Post-Baccalaureate Program in Pharmaceutical

More information

Bioavailability and Bioequivalence Studies

Bioavailability and Bioequivalence Studies Bioavailability and Bioequivalence Studies Standard Approach Part I: Design and Conduct H. Rettig, Ph.D. LLC www.ivivc.com Note for Guidance on the Investigation of Bioavailability and Bioequivalence CPMP/EWP/QWP/1401/98

More information

Pharmacokinetic & Pharmacodynamic Data Analysis

Pharmacokinetic & Pharmacodynamic Data Analysis Pharmacokinetic & Pharmacodynamic Data Analysis CONCEPTS AND APPLICATIONS 4TH EDITION REVISED AND EXPANDED Table of Contents 1. 1.1 1.2 1.3 1.4 1.5 2. 2.1 2.2 2.2.1 2.2.2 2.2.3 2.2.4 2.2.5 2.2.6 2.2.7

More information

201 Business Statistics & Research Methodology

201 Business Statistics & Research Methodology MBA (CC) Part-I (Semester-II) 1 201 Business Statistics & Research Methodology The objective of this course is to have a general understanding of Research Methodology and Statistics as applicable to Business

More information

Analysis of an Acrylic Copolymer using Pyrolysis-GC/MS

Analysis of an Acrylic Copolymer using Pyrolysis-GC/MS FIELD APPLICATION REPORT GAS CHROMATOGRAPHY Analysis of an Acrylic Copolymer using Pyrolysis-GC/MS Author: Thomas Wampler CDS Analytical, Inc. 465 Limestone Road Oxford, PA 19363-0277 Introduction Analytical

More information

Pharmaceutical LC/MS Solutions from Agilent Technologies

Pharmaceutical LC/MS Solutions from Agilent Technologies Pharmaceutical LC/MS Solutions from Agilent Technologies Application Compendium Overview LC/MS plays a key role in the drug discovery and drug development process. Since the introduction of electrospray

More information

Pharmaceutical Sciences/Medicinal Chemistry, Ph.D.

Pharmaceutical Sciences/Medicinal Chemistry, Ph.D. Pharmaceutical Sciences/Medicinal Chemistry, Ph.D. 1 Pharmaceutical Sciences/Medicinal Chemistry, Ph.D. SCHOOL OF PHARMACY (http://www.temple.edu/pharmacy) About the Program The School of Pharmacy offers

More information

Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column

Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column Application Note Bio-Pharmaceutical Authors M. Sundaram Palaniswamy and Andrew Coffey Agilent Technologies,

More information

SUPAC OF IMMEDIATE-RELEASE, MODIFIED- RELEASE AND SEMI-SOLID: A REGULATORY NOTE

SUPAC OF IMMEDIATE-RELEASE, MODIFIED- RELEASE AND SEMI-SOLID: A REGULATORY NOTE SUPAC OF IMMEDIATE-RELEASE, MODIFIED- RELEASE AND SEMI-SOLID: A REGULATORY NOTE Available online at www.ijdra.com REVIEW ARTICLE 1 Ashara Kalpesh C*, 2 Mendapara Vishal P, 2,3 Mori Nitin M, 4 Badjatya

More information

CURRICULUM MASTER OF BUSINESS ADMINISTRATION IN E-GOVERNANCE

CURRICULUM MASTER OF BUSINESS ADMINISTRATION IN E-GOVERNANCE GENERAL SIR JOHN KOTELAWALA DEFENCE UNIVERSITY (MEMBER OF THE ASSOCIATION OF COMMONWEALTHUNIVERSITIESAND INTERNATIONAL ASSOCIATION OF UNIVERSITIES) CURRICULUM MASTER OF BUSINESS ADMINISTRATION IN E-GOVERNANCE

More information

Current Regulatory Thinking The Draft Reflection Paper On Intravenous Liposomal Product Quality Issues

Current Regulatory Thinking The Draft Reflection Paper On Intravenous Liposomal Product Quality Issues Current Regulatory Thinking The Draft Reflection Paper On Intravenous Liposomal Product Quality Issues Dr. René Thürmer BfArM - and dmedical ldevices AGAH Workshop on Liposomal Formulations Bonn / 21.

More information

CURRICULUM MASTER OF BUSINESS ADMINISTRATION IN LOGISTICS MANAGEMENT

CURRICULUM MASTER OF BUSINESS ADMINISTRATION IN LOGISTICS MANAGEMENT GENERAL SIR JOHN KOTELAWALA DEFENCE UNIVERSITY (MEMBER OF THE ASSOCIATION OF COMMONWEALTHUNIVERSITIESAND INTERNATIONAL ASSOCIATION OF UNIVERSITIES) CURRICULUM MASTER OF BUSINESS ADMINISTRATION IN LOGISTICS

More information

Recent FDA Guidance For Industry; BCS Class 1 and 3 August 2015

Recent FDA Guidance For Industry; BCS Class 1 and 3 August 2015 Recent FDA Guidance For Industry; BCS Class 1 and 3 August 2015 Bryan Crist Scientific Affairs Manager, Agilent Technologies, Dissolution Systems Dissolution Exchange WebEx Bryan.crist@agilent.com August,

More information

Revision of 30 April 2013 draft, 4 November 2013

Revision of 30 April 2013 draft, 4 November 2013 GUIDANCE DOCUMENT FOR SINGLE LABORATORY VALIDATION OF QUANTITATIVE ANALYTICAL METHODS USED IN SUPPORT OF PRE- AND POST-REGISTRATION DATA REQUIREMENTS FOR PLANT PROTECTION AND BIOCIDAL PRODUCTS INTRODUCTION

More information

Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C.

Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Specifications Breakout Session 2 Pete Yehl and Mike Coutant, moderators

More information

EVALUATION FOR STABILITY DATA

EVALUATION FOR STABILITY DATA INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION FOR STABILITY DATA Q1E Recommended for

More information

Experimental design on product development

Experimental design on product development Experimental design on product development Introduction What is the traditional developing method? What is experimental design? What do we need and what kind of possibilities do we have for designing?

More information

Performance Testing of Novel Dosage Forms

Performance Testing of Novel Dosage Forms RQA Ireland Regional Forum - Athlone, May 2016 Quality Considerations Pharma and Biopharma Performance Testing of Novel Dosage Forms Terry Way BPharm MAPS Dissolution Science Consultant Glasside Technologies

More information

Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC

Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC The Agilent 126 Infinity Bio-Inert Quaternary LC System and the AdvanceBio SEC 3Å, 2.7 µm Column Application Note Biologics

More information

DECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE

DECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE DECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE Determine impurity level in relevant batches 1 Determine mean + upper confidence limit for the impurity

More information

Agilent solutions for contract research and manufacturing organizations

Agilent solutions for contract research and manufacturing organizations Agilent solutions for contract research and manufacturing organizations Cooperation between pharmaceutical companies and contract research organizations A successful approach to increasing efficiency along

More information

Identification of Drug Metabolites via Mass Spectrometry

Identification of Drug Metabolites via Mass Spectrometry Identification of Drug Metabolites via Mass Spectrometry Besnik Bajrami Chem 395 Outline Introduction What are Drug Metabolites What is Mass Spec Identification of Drug Metabolites Example Conclusion &

More information

Development of paediatric formulations - points to consider

Development of paediatric formulations - points to consider Development of paediatric formulations - points to consider Workshop on Paediatric Formulations II London, 8 November 2011 Presented by: Ann Marie Kaukonen Scientific Administrator, Paediatric Medicines,

More information

Study (s) Degree Center Acad. Period Grado de Farmacia FACULTY OF PHARMACY 3 Annual PDG Farmacia-Nutrición Humana y Dietética

Study (s) Degree Center Acad. Period Grado de Farmacia FACULTY OF PHARMACY 3 Annual PDG Farmacia-Nutrición Humana y Dietética COURSE DATA Data Subject Code 34081 Name Biopharmacy and Pharmacokinetics Cycle Grade ECTS Credits 10.5 Academic year 2014-2015 Study (s) Degree Center Acad. Period year 1201 - Grado de Farmacia FACULTY

More information

Research Paper Development of Stability Indicating Reverse Phase HPLC Method for Aripiprazole from Solid Dosage form

Research Paper Development of Stability Indicating Reverse Phase HPLC Method for Aripiprazole from Solid Dosage form International Journal of Pharmaceutical Sciences and Nanotechnology 572 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 2 Issue 2 July - September 2009 Volume 2 Issue 2 July

More information

3M Purification Inc. Technical and Scientific Services Global Support for the Life Science Industry. Global Expertise delivered locally

3M Purification Inc. Technical and Scientific Services Global Support for the Life Science Industry. Global Expertise delivered locally 3M Purification Inc. Technical and Scientific Services Global Support for the Life Science Industry Global Expertise delivered locally Global expertise delivered locally As a global leader in measuring,

More information

School of Pharmacy TEMPLE UNIVERSITY

School of Pharmacy TEMPLE UNIVERSITY School of Pharmacy TEMPLE UNIVERSITY Regulatory Affairs and Quality Assurance Graduate Program Te mple Unive rsity School of Pharmacy Re gulatory Affairs and Quality Assurance Graduate Program 4 25 Comme

More information

ADAMAS UNIVERSITY FACULTY OF SCIENCE - DEPARTMENT OF BIOTECHNOLOGY BACHELOR OF SCIENCE (Honours) SEMESTER - I

ADAMAS UNIVERSITY FACULTY OF SCIENCE - DEPARTMENT OF BIOTECHNOLOGY BACHELOR OF SCIENCE (Honours) SEMESTER - I NEW CHOICE BASED CREDIT SYSTEM (TOTAL CREDIT = 22+22+28+28+26+26 = 152) Type of the Paper Paper Code ADAMAS UNIVERSITY FACULTY OF SCIENCE - DEPARTMENT OF BIOTECHNOLOGY SEMESTER - I / Brief Contents I BT1201

More information

Guideline for the Quality, Safety, and Efficacy Assurance of Follow-on Biologics

Guideline for the Quality, Safety, and Efficacy Assurance of Follow-on Biologics Provisional Translation (as of April 19, 2013) PFSB/ELD Notification No. 0304007 March 4, 2009 To: Prefectural Health Department (Bureau) From: Evaluation and Licensing Division, Pharmaceutical and Food

More information

FORMULATION & LYOPHILIZATION CYCLE DEVELOPMENT OF AN ADC

FORMULATION & LYOPHILIZATION CYCLE DEVELOPMENT OF AN ADC FORMULATION & LYOPHILIZATION CYCLE DEVELOPMENT OF AN ADC A Case Study Wendy Saffell-Clemmer Director, R&D Baxter BioPharma Solutions Antibody Drug Conjugates (ADCs) are complex molecules consisting of

More information

Microbiology, Molecular Biology and Biochemistry

Microbiology, Molecular Biology and Biochemistry Microbiology, Molecular Biology and Biochemistry Bruce L. Miller, Interim Dept. Head, Dept. of Microbiology, Molecular Biology and Biochemistry (142 Life Sc. Bldg. 83844-3052; phone 208/885-7966; mmbb@uidaho.edu;

More information

Approval Review of Generic Drugs. Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D.

Approval Review of Generic Drugs. Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D. Approval Review of Generic Drugs Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D. Outline of Presentation Introduction Approval Review of Generic Drugs Equivalency review Conformity audit Conclusion

More information

Eurofins ADME BIOANALYSES Your partner in drug development

Eurofins ADME BIOANALYSES Your partner in drug development Eurofins ADME BIOANALYSES Your partner in drug development Since 1987, you have placed your confidence in us. Our responsibility, to which my staff and I commit, is to consistently provide you with relevant

More information

Fe doped Magnetic Nanodiamonds made by Ion

Fe doped Magnetic Nanodiamonds made by Ion Fe doped Magnetic Nanodiamonds made by Ion Implantation ChienHsu Chen a, I.C. Cho b, Hui-Shan Jian c and H. Niu a* a Nuclear Science and Technology Development Center, National Tsing Hua University, HsinChu

More information

Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA )

Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA ) Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA ) Area 1.0 Basic Biomedical Sciences (10%) Area 2.0 Pharmaceutical Sciences (33%) Area 3.0 Social/Behavioral/Administrative Sciences (22%)

More information

Industry Perspective on Manufacturing in Early Development

Industry Perspective on Manufacturing in Early Development Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical

More information

October 26-27, 2017 in Mumbai, India

October 26-27, 2017 in Mumbai, India ELECTROLAB, in collaboration with Simulations Plus, presents: The 2-Day GastroPlus Pharmaceutical Development Workshop October 26-27, 2017 in Mumbai, India Electrolab, in collabration with Simulations

More information

Types of chromatography

Types of chromatography Chromatography Physical separation method based on the differential migration of analytes in a mobile phase as they move along a stationary phase. Mechanisms of Separation: Partitioning Adsorption Exclusion

More information

Need and Application of Analytical Method Development on New Fixed Dose Combination of Irbesartan and Atorvastatin in Pharmaceutical Industry

Need and Application of Analytical Method Development on New Fixed Dose Combination of Irbesartan and Atorvastatin in Pharmaceutical Industry 43 Review Article Need and Application of Analytical Method Development on New Fixed Dose Combination of Irbesartan and Atorvastatin in Pharmaceutical Industry Paras Virani 1,2 *, Parul Jain 3, Hasumati

More information

DRUG REGISTRATION REGULATION

DRUG REGISTRATION REGULATION DRUG REGISTRATION REGULATION Registration Categories and Application Information Items Requirements of Biological Products Part I I Therapeutic Biological Products Registration Categories 1) Biological

More information

ICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers

ICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers European Medicines Agency August 2003 CPMP/ICH/4680/02 ICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers

More information

DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY

DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY Department of Biochemistry and Molecular Biology 1 DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY Office in Molecular and Radiological Biosciences Building, Room 111 (970) 491-5602 bmb.colostate.edu

More information

Tony Mire-Sluis Vice President, Corporate, Product and Device Quality Amgen Inc

Tony Mire-Sluis Vice President, Corporate, Product and Device Quality Amgen Inc The Regulatory Implications of the ever increasing power of Mass Spectrometry and its role in the Analysis of Biotechnology Products Where do we draw the line? Tony Mire-Sluis Vice President, Corporate,

More information

Pre-Screening revised checklist for BA/BE NOC for Export Purpose

Pre-Screening revised checklist for BA/BE NOC for Export Purpose Pre-Screening revised checklist for BA/BE NOC for Export Purpose O/o Drugs Controller General (India) Directorate General of Health Services FDA Bhawan, New Delhi (With effective from 25 th April 2014)

More information

METHCATHINONE Latest Revision: July 11, 2005

METHCATHINONE Latest Revision: July 11, 2005 METHCATHINONE Latest Revision: July 11, 2005 O CH 3 HN CH 3 1. SYNONYMS CFR: Methcathinone CAS #: Base: 5650-44-2 Hydrochloride: 49656-78-2 Other Names: N-methylcathinone Methylcathinone 2-Methylamino-1-phenyl-1-propanone

More information

Structure and content of an IMPD. What is required for first into man trial?

Structure and content of an IMPD. What is required for first into man trial? What is required for first into man? The EU IMPD Thomas Sudhop, MD Scope Structure and content of an IMPD What is required for first into man trial? Only for IMPs that do not have a marketing authorisation

More information

fnyyh fo ofo ky; UNIVERSITY OF DELHI SEMESTER EXAMINATIONS - (MAY-2018)

fnyyh fo ofo ky; UNIVERSITY OF DELHI SEMESTER EXAMINATIONS - (MAY-2018) TENTATIVE fnyyh fo ofo ky; UNIVERSITY OF DELHI SEMESTER EXAMINATIONS - (MAY-2018) Date-Sheet for B.Sc. (Programme) Choice Based Credit System Exam (CBCS) Semester Scheme (Admissions of 2015, 2016 & 2017)

More information

Polymer Degradation Mechanisms using Pyrolysis- GC/MS

Polymer Degradation Mechanisms using Pyrolysis- GC/MS FIELD APPLICATION REPORT GAS CHROMATOGRAPH Y Polymer Degradation Mechanisms using Pyrolysis- GC/MS Author: Thomas Wampler CDS Analytical, Inc. 465 Limestone Road Oxford, PA 19363-0277 Introduction The

More information